Guggenheim analyst Brad Canino initiated coverage of Tyra Biosciences (TYRA) with a Buy rating and $54 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TYRA:
- Canaccord starts Tyra Biosciences at Buy into 2026 data readouts
- Tyra Biosciences initiated with a Buy at Canaccord
- Tyra Bioscience Strengthens Financial Leadership with New Officer
- Tyra Biosciences price target raised to $56 from $42 at Piper Sandler
- Tyra Bioscience Raises $126 Million in Block Share Sale